Multiple marker second trimester serum screening for pre-eclampsia

Journal of Medical Screening

Volumn 8, Issue 2, 2001, Pages 65-68

  Wald, N J ^a   Morris, J K ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Free human chorionic gonadotropin; Inhibin A; Pre eclampsia; Screening; Unconjugated estriol

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A;

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MATERNAL DISEASE; MATERNAL MORBIDITY; MATERNAL SERUM; PREECLAMPSIA; PROTEINURIA; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ESTRIOL; FEMALE; HUMANS; INHIBINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTEINURIA;

EID: 0034928110     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.8.2.65     Document Type: Article

References (25)

1. Eclampsia in the United Kingdom
2. Disorders associated with high blood pressure
3. Down's syndrome
4. Maternal serum human chorionic gonadotrophin level at 15 weeks is a predictor for pre-eclampsia
5. The value of elevated second-trimester β-human chorionic gonadotrophin in predicting development of pre-eclampsia
6. Elevated second-trimester human chorionic gonadotrophin levels in association with poor pregnancy outcome
7. Second-trimester levels in maternal serum human chorionic gonadotrophin and inhibin A as predictors of pre-eclampsia in the third trimester of pregnancy
8. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrephin for the prediction of pre-eclampsia
9. Midtrimester N-terminal proatrial natriuretic peptide, free β-hCG, and α-fetoprotein in predicting pre-eclampsia
10. Elevated second trimester human chorionic gonadotrophin levels associated with adverse pregnancy outcome
11. Activin A and inhibin A as possible endocrine markers for pre-eclampsia
12. Maternal serum inihibin A can predict pre-eclampsia
13. Second-trimester maternal serum inhibin A concentration as an early marker for pre-eclampsia
14. Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation associated with pre-eclampsia
15. Inhibin A and activin A levels in the second trimester as predictors of pre-eclampsia
16. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia
17. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP, and free β-hCG levels
18. The association between maternal serum α-fetoprotein and preterm birth, small for gestational age infants, pre-eclampsia, and placental complications
19. Can antenatal clinical and biochemical markers predict the development of severe pre-eclampsia?
20. Tests using multiple markers
21. Serum levels of activin A and inhibin A and the subsequent development of pre-eclampsia
22. Drugs for rapid treatment of very high blood pressure during pregnancy
23. Antiplatelet agents for preventing and treating pre-eclampsia
24. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomised trial